Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Bond Biosciences, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Bond Biosciences, Inc.

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Other Health Care

SEC CIK: 0001824224

Founded: —Source: [SEC]
Headquarters: Parkville, MISSOURISource: [SEC]
Headcount: 3Source: [SEC]
Stage: Series A
Sector: Healthcare

$5.9MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Overview

Bond Biosciences has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $299,359 in 2021. These are non-dilutive federal research grants, not equity financing. The company is based in New York, New York.

Funding rounds

2 rounds

SBIR Phase I award (HHS)GrantAug 2021Source: [GOV]
$299.4K
—post-money
Private placement (Form D)

Investors

No investors recorded yet for Bond Biosciences, Inc..

Add an investor

People

Leadership

Michael BeckloffDirectorSince 2026Source: [SEC]

Cory BerklandExecutive OfficerSince 2026Source: [SEC]

Showing 2 of 5 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Acquisitions

Bond Biosciences, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Bond Biosciences, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Apr 2026Source: [SEC]

$5.9M

—post-money